CROSS COUNTRY (NASDAQ: CCRN) CAO gets 9,043 RSUs, 938 shares withheld for taxes

Rhea-AI Filing Summary

CROSS COUNTRY HEALTHCARE INC Chief Accounting Officer Marvin Veizaga reported equity compensation activity in company stock. He received a grant of 9,043 shares of common stock, described as restricted shares that vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. To cover tax withholding obligations for restricted stock that vested on March 31, 2026, 938 shares were withheld in two transactions at $9.40 per share. After these transactions and a correction for 4,471 previously omitted shares from an earlier Form 3, Veizaga directly holds 31,716 shares of common stock.

Insights

Equity compensation analyst

Routine stock grant and tax withholding leave CAO with larger CCRN equity stake.

Chief Accounting Officer Marvin Veizaga received 9,043 restricted shares of CROSS COUNTRY HEALTHCARE INC common stock as compensation. These shares vest in three substantially equal tranches on March 31, 2027, March 31, 2028, and March 31, 2029, aligning his incentives with longer-term company performance.

Two F-code transactions totaling 938 shares at $9.40 per share were withheld to satisfy tax obligations on previously vested restricted stock, not open-market sales. A footnote also corrects an earlier Form 3 by adding 4,471 shares that were inadvertently omitted. Following all adjustments, Veizaga directly owns 31,716 shares, indicating an overall increase in his reported equity position.

Insider Trade Summary

Net Buyer: 8,105 shares

Net Buy 3 txns

Insider Veizaga Marvin

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,043	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	501	$9.40	$5K
Exercise Price or Tax Liability	Common Stock	437	$9.40	$4K

Holdings After Transaction: Common Stock — 31,716 shares (Direct)

Footnotes (3)

1. F1. These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.
2. F2. Reflects an additional 4,471 shares of common stock that were inadvertently omitted from the Reporting Person's Form 3 filed on March 25, 2026.
3. F3. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

Key Figures

Restricted stock grant: 9,043 shares Tax withholding shares: 938 shares Withholding price: $9.40 per share +2 more

5 metrics

Restricted stock grant 9,043 shares Common stock award to CAO on March 31, 2026

Tax withholding shares 938 shares Shares withheld to satisfy tax obligations on March 31, 2026

Withholding price $9.40 per share Price used for F-code tax-withholding dispositions

Shares after transactions 31,716 shares Direct CCRN common stock holdings following reported activity

Omitted shares correction 4,471 shares Additional shares omitted from Form 3 and now reflected

Key Terms

restricted shares of common stock, tax withholding obligations, Form 3

3 terms

restricted shares of common stock financial

"These restricted shares of common stock vest in three substantially equal installments."

Restricted shares of common stock are company shares that cannot be sold or transferred until specific conditions are met, such as a set time period, performance targets, or regulatory approvals; they are often granted to founders, employees or early investors. They matter to investors because when the restrictions lift those shares can enter the market and increase the supply, potentially diluting existing holders and changing the stock’s price, similar to a locked faucet being opened and more water joining the flow.

tax withholding obligations financial

"These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026."

Form 3 regulatory

"Reflects an additional 4,471 shares of common stock that were inadvertently omitted from the Reporting Person's Form 3 filed on March 25, 2026."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 04/02/2026 - 04:06 PM Learn about SEC filing dates

FAQ

What stock award did CCRN Chief Accounting Officer Marvin Veizaga receive?

Marvin Veizaga received a grant of 9,043 restricted shares of CROSS COUNTRY HEALTHCARE INC common stock. These shares vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029, providing long-term, stock-based compensation.

How do the new restricted shares for CCRN’s CAO vest over time?

The 9,043 restricted shares awarded to CCRN Chief Accounting Officer Marvin Veizaga vest in three substantially equal installments. The vesting dates are March 31, 2027, March 31, 2028, and March 31, 2029, creating a multi-year incentive structure tied to continued service.

Why were some CCRN shares disposed of in Marvin Veizaga’s Form 4?

Two Form 4 transactions reflecting 938 shares were coded “F” for tax withholding. These shares were withheld at $9.40 per share to satisfy tax obligations from restricted stock that vested on March 31, 2026, rather than representing discretionary open-market sales.

How many CCRN shares does Marvin Veizaga own after the reported transactions?

After the grant, tax withholding, and a correction to prior reporting, Marvin Veizaga directly holds 31,716 shares of CROSS COUNTRY HEALTHCARE INC common stock. This final holding reflects both the new restricted stock award and the shares withheld for tax obligations.

What correction to prior CCRN ownership reporting was disclosed for Marvin Veizaga?

A footnote states that 4,471 shares of CCRN common stock were inadvertently omitted from Marvin Veizaga’s Form 3 filed on March 25, 2026. The current Form 4 updates his reported holdings to include these additional shares accurately.

What does transaction code “F” mean in the CCRN Form 4 for Marvin Veizaga?

In this CCRN Form 4, transaction code “F” indicates shares delivered to pay tax obligations. Specifically, 938 shares of common stock were withheld at $9.40 per share to satisfy tax withholding for restricted stock that vested on March 31, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Veizaga Marvin

(Last) (First) (Middle)

C/O CROSS COUNTRY HEALTHCARE, INC.

5201 CONGRESS AVENUE, SUITE 160

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		9,043(1)	A	$0	32,654(2)	D
Common Stock	03/31/2026		F		501(3)	D	$9.4	32,153	D
Common Stock	03/31/2026		F		437(3)	D	$9.4	31,716	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

2. Reflects an additional 4,471 shares of common stock that were inadvertently omitted from the Reporting Person's Form 3 filed on March 25, 2026.

3. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

	/s/ Marvin Veizaga	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)